Publications

Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection.

Elkins MK, Vittinghoff E, Baranzini SE, Hecht FM, Sriram U, Busch MP, Levy JA, Oksenberg JR

Genes and immunity, 2005

Transcription-based prediction of response to IFNbeta using supervised computational methods.

Baranzini SE, Mousavi P, Rio J, Caillier SJ, Stillman A, Villoslada P, Wyatt MM, Comabella M, Greller LD, Somogyi R, Montalban X, Oksenberg JR

PLoS biology, 2004

Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain.

Baranzini SE

Neuromolecular medicine, 2004

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL

American journal of human genetics, 2003

Dynamic regulation of alternative ATP-binding cassette transporter A1 transcripts.

Huuskonen J, Abedin M, Vishnu M, Pullinger CR, Baranzini SE, Kane JP, Fielding PE, Fielding CJ

Biochemical and biophysical research communications, 2003

Osteopontin polymorphisms and disease course in multiple sclerosis.

Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR

Genes and immunity, 2003

Direct deletion analysis in two Duchenne muscular dystrophy symptomatic females using polymorphic dinucleotide (CA)n loci within the dystrophin gene.

Giliberto F, Ferreiro V, Dalamón V, Surace E, Cotignola J, Esperante S, Borelina D, Baranzini S, Szijan I

Journal of biochemistry and molecular biology, 2003

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR

Genes and immunity, 2003

Large-scale gene-expression studies and the challenge of multiple sclerosis.

Baranzini SE, Hauser SL

Genome biology, 2002

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.

Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J, Baranzini SE, Casquero P, Hauser SL, Montalban X, Oksenberg JR

Journal of neuroimmunology, 2002

Pages